Community Regional Cancer Care — Indianapolis, Indiana

Community Regional Cancer Care is a clinical research site located in Indianapolis, Indiana, United States 46250.

Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.

Community Regional Cancer Care has participated in 14 clinical trials with 1 currently active.

Therapeutic areas: Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV, Lung Cancer.

Sponsors: EMD Serono Research & Development Institute, Inc., Radiation Therapy Oncology Group, Jason R. Brown.

Sponsor Feasibility Report

Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Community Regional Cancer Care?

Community Regional Cancer Care has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Community Regional Cancer Care conducted?

Community Regional Cancer Care has 14 clinical trials on record, with 1 currently active. Their work covers Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV, Lung Cancer.

Is Community Regional Cancer Care accredited by Crixeo Health?

Yes — Community Regional Cancer Care holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Community Regional Cancer Care?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.